| 臺大學術典藏 |
2021-03-18T02:02:23Z |
Increased Expression of Programmed Death-Ligand 1 in Infiltrating Immune Cells in Hepatocellular Carcinoma Tissues after Sorafenib Treatment
|
Lu L.-C.;Lee Y.-H.;Chang C.-J.;Chia-Tung Shun;Fang C.-Y.;Shao Y.-Y.;Liu T.-H.;Cheng A.-L.;Hsu C.-H.; Lu L.-C.; Lee Y.-H.; Chang C.-J.; CHIA-TUNG SHUN; Fang C.-Y.; Shao Y.-Y.; Liu T.-H.; Cheng A.-L.; Hsu C.-H. |
| 臺大學術典藏 |
2021-03-15T07:44:44Z |
Considerations of heterogeneity in clinical trials for hepatocellular carcinoma
|
Liu T.-H.;Shao Y.-Y.;Li-Chun Lu;Shen Y.-C.;Hsu C.;Lin Z.-Z.;Hsu C.-H.;Cheng A.-L.; Liu T.-H.; Shao Y.-Y.; LI-CHUN LU; Shen Y.-C.; Hsu C.; Lin Z.-Z.; Hsu C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-03-15T07:44:44Z |
Increased Expression of Programmed Death-Ligand 1 in Infiltrating Immune Cells in Hepatocellular Carcinoma Tissues after Sorafenib Treatment
|
Li-Chun Lu;Lee Y.-H.;Chang C.-J.;Shun C.-T.;Fang C.-Y.;Shao Y.-Y.;Liu T.-H.;Cheng A.-L.;Hsu C.-H.; LI-CHUN LU; Lee Y.-H.; Chang C.-J.; Shun C.-T.; Fang C.-Y.; Shao Y.-Y.; Liu T.-H.; Cheng A.-L.; Hsu C.-H. |
| 臺大學術典藏 |
2021-03-15T07:44:43Z |
Early alpha-foetoprotein response associated with treatment efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma
|
Shao Y.-Y.;Liu T.-H.;Hsu C.;Li-Chun Lu;Shen Y.-C.;Lin Z.-Z.;Cheng A.-L.;Hsu C.-H.; Shao Y.-Y.; Liu T.-H.; Hsu C.; LI-CHUN LU; Shen Y.-C.; Lin Z.-Z.; Cheng A.-L.; Hsu C.-H. |
| 臺大學術典藏 |
2021-03-15T07:44:43Z |
Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
|
Li-Chun Lu;Hsu C.;Shao Y.-Y.;Chao Y.;Yen C.-J.;Shih I.-L.;Hung Y.-P.;Chang C.-J.;Shen Y.-C.;Guo J.-C.;Liu T.-H.;Hsu C.-H.;Cheng A.-L.; LI-CHUN LU; Hsu C.; Shao Y.-Y.; Chao Y.; Yen C.-J.; Shih I.-L.; Hung Y.-P.; Chang C.-J.; Shen Y.-C.; Guo J.-C.; Liu T.-H.; Hsu C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-03-11T08:34:17Z |
Outcome of stage IV cancer patients receiving in-hospital cardiopulmonary resuscitation: a population-based cohort study
|
Lee M.-R.;Yu K.-L.;Kuo H.-Y.;Liu T.-H.;Jen-Chang Ko;Tsai J.-S.;Wang J.-Y.; MENG-RUI LEE; KAI-LUN YU; HUNG-YANG KUO; Tsung-Hao Liu; JEN-CHANG KO; Tsai J.-S.; Wang J.-Y. |
| 臺大學術典藏 |
2021-03-11T08:29:32Z |
Outcome of stage IV cancer patients receiving in-hospital cardiopulmonary resuscitation: a population-based cohort study
|
Lee M.-R.; Yu K.-L.; Kuo H.-Y.; Liu T.-H.; JEN-CHANG KO; Tsai J.-S.; Wang J.-Y. |
| 臺大學術典藏 |
2021-03-11T07:58:27Z |
Outcome of stage IV cancer patients receiving in-hospital cardiopulmonary resuscitation: a population-based cohort study
|
Lee M.-R.; Yu K.-L.; Kuo H.-Y.; Liu T.-H.; JEN-CHANG KO; Tsai J.-S.; Wang J.-Y. |
| 臺大學術典藏 |
2021-03-09T05:18:31Z |
Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
|
Lu L.-C.; Hsu C.; Shao Y.-Y.; Chao Y.; Yen C.-J.; Shih I.-L.; Hung Y.-P.; Chang C.-J.; Ying-Chun Shen; Guo J.-C.; Liu T.-H.; Hsu C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-03-09T05:18:31Z |
Considerations of heterogeneity in clinical trials for hepatocellular carcinoma
|
Liu T.-H.; Shao Y.-Y.; Lu L.-C.; Ying-Chun Shen; Hsu C.; Lin Z.-Z.; Hsu C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-02-25T07:00:57Z |
It takes two to tango: breakthrough advanced hepatocellular carcinoma treatment that combines anti-angiogenesis and immune checkpoint blockade
|
Liu T.-H.; YU-YUN SHAO; Hsu C.-H. |
| 臺大學術典藏 |
2021-02-19T06:52:25Z |
It takes two to tango: breakthrough advanced hepatocellular carcinoma treatment that combines anti-angiogenesis and immune checkpoint blockade
|
Liu T.-H.;Shao Y.-Y.;Chih-Hung Hsu; Liu T.-H.; Shao Y.-Y.; CHIH-HUNG HSU |
| 臺大學術典藏 |
2021-02-18T08:38:07Z |
A case of human infection with Anisakis simplex in Taiwan
|
Li S.-W.; Shiao S.-H.; Weng S.-C.; Liu T.-H.; Su K.-E.; CHIEN-CHUAN CHEN |
| 臺大學術典藏 |
2021-02-18T02:33:48Z |
Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
|
Lu L.-C.;Shao Y.-Y.;Chao Y.;Yen C.-J.;Shih I.-L.;Hung Y.-P.;Chang C.-J.;Shen Y.-C.;Guo J.-C.;Liu T.-H.;Chiun Hsu;Cheng A.-L.; Lu L.-C.; Shao Y.-Y.; Chao Y.; Yen C.-J.; Shih I.-L.; Hung Y.-P.; Chang C.-J.; Shen Y.-C.; Guo J.-C.; Liu T.-H.; Chiun Hsu; Cheng A.-L. |
| 臺大學術典藏 |
2021-02-18T02:33:48Z |
Early alpha-foetoprotein response associated with treatment efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma
|
Shao Y.-Y.;Liu T.-H.;Chiun Hsu;Lu L.-C.;Shen Y.-C.;Lin Z.-Z.;Cheng A.-L.; Shao Y.-Y.; Liu T.-H.; Chiun Hsu; Lu L.-C.; Shen Y.-C.; Lin Z.-Z.; Cheng A.-L. |
| 臺大學術典藏 |
2021-02-18T01:45:21Z |
Novel systemic therapy for hepatocellular carcinoma
|
Dong Y.;Liu T.-H.;Yau T.;Chiun Hsu; Dong Y.; Liu T.-H.; Yau T.; Chiun Hsu |
| 臺大學術典藏 |
2021-02-04T07:33:05Z |
Doses of hepatitis B revaccination needed for the seronegative youths to be seropositive to antibody against hepatitis B surface antigen
|
Jan C.-F.;Liu T.-H.;Ho C.-H.;Chien Y.-C.;Chang C.-J.;Fei-Ran Guo;Huang K.-C.; Jan C.-F.; Liu T.-H.; Ho C.-H.; Chien Y.-C.; Chang C.-J.; FEI-RAN GUO; Huang K.-C. |
| 臺大學術典藏 |
2021-01-15T03:46:25Z |
Urinary trypsinogen-2 level and local complications of acute pancreatitis
|
Wu H.-C.; HSIU-PO WANG; Chen C.-C.; Wu C.-H.; Liu T.-H.; Wang C.-H.; Shih L.-N.; Liao W.-C. |
| 臺大學術典藏 |
2021-01-14T06:25:55Z |
Doses of hepatitis B revaccination needed for the seronegative youths to be seropositive to antibody against hepatitis B surface antigen
|
Chyi-Feng Jan;Liu T.-H.;Ho C.-H.;Chien Y.-C.;Chang C.-J.;Guo F.-R.;Huang K.-C.; CHYI-FENG JAN; Liu T.-H.; Ho C.-H.; Chien Y.-C.; Chang C.-J.; Guo F.-R.; Huang K.-C. |
| 臺大學術典藏 |
2021-01-14T03:08:40Z |
Doses of hepatitis B revaccination needed for the seronegative youths to be seropositive to antibody against hepatitis B surface antigen
|
Jan C.-F.; Liu T.-H.; Ho C.-H.; Chien Y.-C.; Chang C.-J.; Guo F.-R.; KUO-CHIN HUANG |
| 臺大學術典藏 |
2021-01-12T05:55:05Z |
Entrenchment and Creativity in Chinese Quadrasyllabic Idiomatic Expressions
|
Hsieh, S.-K.;Chou, T.-L.;Lee, C.-L.;Su, I-W.;Lu, C.-R.;Liu, T.-H.;Tsai, I-N.;T'sou, B.; Tsai, I-Ni; Hsieh, S.-K.; I-NI TSAI |
| 臺大學術典藏 |
2021-01-12T05:55:04Z |
Entrenchment in Chinese Quadra-syllabic Idiomatic Expressions: A fMRI Study
|
Hsieh, S.-K.;Chou, T.-L.;Tseng, Y.-H.;Chiang, C.-Y.;Lee, C.-L.;Liu, T.-H.;Lu, C.-R.;Tsai, I-N.;Su, I-W.; Tsai, I-Ni; Hsieh, S.-K.; I-NI TSAI |
| 臺大學術典藏 |
2021-01-12T05:55:04Z |
Effects of Frequency and Construction on the Interpretation of Chinese Quadrisyllabic Idiomatic Expressions: An fMRI Study
|
Liu, T.-H.;Su, I-W.;Lai, C.-H.;Hsieh, S.-K.;Lee, C.-L.;Lu, C.-R.;Tsai, I-N.;Chou, T.-L.; Tsai, I-Ni; Liu, T.-H.; I-NI TSAI |
| 臺大學術典藏 |
2021-01-12T05:55:04Z |
Right Hemisphere Contribution in Syntactic Category Processing in L2 _ERP and fMRI Data from Learners of Mandarin Chinese
|
Lai, C.-H.;Yeh, C.;Chen, P.-H.;Lee, C.-L.;Hsieh, S.-K.;Su, I-W.;Liu, T.-H.;Lu, C.-R.;Tsai, I-N.;Chou, T.-L.; Tsai, I-Ni; Lai, C.-H.; I-NI TSAI |
| 臺大學術典藏 |
2021-01-12T03:00:18Z |
Outcome of stage IV cancer patients receiving in-hospital cardiopulmonary resuscitation: a population-based cohort study
|
Ko J.-C.; Kuo H.-Y.; Liu T.-H.; KAI-LUN YU; Lee M.-R.; Tsai J.-S.; Wang J.-Y. |
